These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Protection against alloxan-induced diabetes by various urea derivatives: relationship between protective effects and reactivity with the hydroxyl radical. Tibaldi J, Benjamin J, Cabbat FS, Heikkila RE. J Pharmacol Exp Ther; 1979 Nov; 211(2):415-8. PubMed ID: 501570 [Abstract] [Full Text] [Related]
6. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy. Martin E, Thougaard AV, Grauslund M, Jensen PB, Bjorkling F, Hasinoff BB, Tjørnelund J, Sehested M, Jensen LH. Toxicology; 2009 Jan 08; 255(1-2):72-9. PubMed ID: 19010377 [Abstract] [Full Text] [Related]
7. A mouse model for studying the interaction of bisdioxopiperazines with topoisomerase IIalpha in vivo. Grauslund M, Thougaard AV, Füchtbauer A, Hofland KF, Hjorth PH, Jensen PB, Sehested M, Füchtbauer EM, Jensen LH. Mol Pharmacol; 2007 Oct 08; 72(4):1003-14. PubMed ID: 17622580 [Abstract] [Full Text] [Related]
8. Effect of superoxide dismutase, catalase, chelating agents, and free radical scavengers on the toxicity of alloxan to isolated pancreatic islets in vitro. Jörns A, Tiedge M, Lenzen S, Munday R. Free Radic Biol Med; 1999 May 08; 26(9-10):1300-4. PubMed ID: 10381203 [Abstract] [Full Text] [Related]
10. Comparison of the protective effect of ICRF-187 and structurally related analogues against acute daunorubicin toxicity in Syrian golden hamsters. Herman EH, el-Hage AN, Creighton AM, Witiak DT, Ferrans VJ. Res Commun Chem Pathol Pharmacol; 1985 Apr 08; 48(1):39-55. PubMed ID: 3922023 [Abstract] [Full Text] [Related]
11. Protection against alloxan-induced diabetes by various dialkyldithiocarbamates. Masukawa T, Nakanishi K, Katakawa J, Tetsumi T. Experientia; 1995 Jan 15; 51(1):29-31. PubMed ID: 7843327 [Abstract] [Full Text] [Related]
12. The hydrolysis activation of the doxorubicin cardioprotective agent ICRF-187 [+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane). Hasinoff BB. Drug Metab Dispos; 1990 Jan 15; 18(3):344-9. PubMed ID: 1974197 [Abstract] [Full Text] [Related]
15. The interaction of the cardioprotective agent ICRF-187 [+)-1,2-bis(3,5-dioxopiperazinyl-1-yL)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycin. Hasinoff BB. Agents Actions; 1989 Mar 15; 26(3-4):378-85. PubMed ID: 2544086 [Abstract] [Full Text] [Related]
16. Mogrosides extract from Siraitia grosvenori scavenges free radicals in vitro and lowers oxidative stress, serum glucose, and lipid levels in alloxan-induced diabetic mice. Qi XY, Chen WJ, Zhang LQ, Xie BJ. Nutr Res; 2008 Apr 15; 28(4):278-84. PubMed ID: 19083420 [Abstract] [Full Text] [Related]